Jill Reckless & Jon Heal - outsourcing drug development

Jill Reckless, CEO and co-founder of RxCelerate, and Jon Heal, Head of In Silico Designs at RxCelerate, discuss the virtual biotech industry, outsourcing drug development, and using bioinformatics for target optimization.
The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.
bioinformaticscro.com